[go: up one dir, main page]

CL2013003066A1 - Composition for treatment of wounds because it comprises support matrix and stem cells mesenchymics of wharton jelly; method for treating wounds comprising applying said composition - Google Patents

Composition for treatment of wounds because it comprises support matrix and stem cells mesenchymics of wharton jelly; method for treating wounds comprising applying said composition

Info

Publication number
CL2013003066A1
CL2013003066A1 CL2013003066A CL2013003066A CL2013003066A1 CL 2013003066 A1 CL2013003066 A1 CL 2013003066A1 CL 2013003066 A CL2013003066 A CL 2013003066A CL 2013003066 A CL2013003066 A CL 2013003066A CL 2013003066 A1 CL2013003066 A1 CL 2013003066A1
Authority
CL
Chile
Prior art keywords
composition
wounds
mesenchymics
treatment
applying
Prior art date
Application number
CL2013003066A
Other languages
Spanish (es)
Inventor
Alvarado Veronica Alejandra Palma
Merino Maria Rosa Bono
Original Assignee
Univ Chile
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Chile filed Critical Univ Chile
Priority to CL2013003066A priority Critical patent/CL2013003066A1/en
Publication of CL2013003066A1 publication Critical patent/CL2013003066A1/en
Priority to PCT/CL2014/000055 priority patent/WO2015058318A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A61L15/325—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/60—Materials for use in artificial skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/64—Animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cell Biology (AREA)
  • Neurology (AREA)
  • Vascular Medicine (AREA)
  • Neurosurgery (AREA)
  • Materials Engineering (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Obesity (AREA)
  • Developmental Biology & Embryology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)

Abstract

LA INVEN´CIÓN PROPORCIONA UNA COMPOSICION PARA TRATAMIENTO DE HERIDAS PORQUE COMPRENDE MATRIZ SOPORTE Y CÉLULAS TRONCALESMESENQUIÁMICAS DE GELATINA DE WHARTON; METODO PARA TRATAR HERIDAS QUE COMPRENDE APLICAR DICHA COMPOSICIONTHE INVENTION PROVIDES A COMPOSITION FOR WOUND TREATMENT BECAUSE IT INCLUDES SUPPORT MATRIX AND TRONCHAL MESENCHIAMIC GELATIN CELLS; METHOD TO TREAT WOUNDS THAT YOU UNDERSTAND TO APPLY SUCH COMPOSITION

CL2013003066A 2013-10-22 2013-10-22 Composition for treatment of wounds because it comprises support matrix and stem cells mesenchymics of wharton jelly; method for treating wounds comprising applying said composition CL2013003066A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CL2013003066A CL2013003066A1 (en) 2013-10-22 2013-10-22 Composition for treatment of wounds because it comprises support matrix and stem cells mesenchymics of wharton jelly; method for treating wounds comprising applying said composition
PCT/CL2014/000055 WO2015058318A1 (en) 2013-10-22 2014-10-20 Composition for accelerating or improving the healing of wounds, and method for accelerating or improving the healing of wounds, comprising the application of said composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2013003066A CL2013003066A1 (en) 2013-10-22 2013-10-22 Composition for treatment of wounds because it comprises support matrix and stem cells mesenchymics of wharton jelly; method for treating wounds comprising applying said composition

Publications (1)

Publication Number Publication Date
CL2013003066A1 true CL2013003066A1 (en) 2014-07-25

Family

ID=52020872

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2013003066A CL2013003066A1 (en) 2013-10-22 2013-10-22 Composition for treatment of wounds because it comprises support matrix and stem cells mesenchymics of wharton jelly; method for treating wounds comprising applying said composition

Country Status (2)

Country Link
CL (1) CL2013003066A1 (en)
WO (1) WO2015058318A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106310369A (en) * 2016-09-29 2017-01-11 广州赛莱拉干细胞科技股份有限公司 Composition, 3D (three-dimensional) dressing with composition and preparation method thereof
EP3456363B1 (en) * 2017-09-18 2020-11-04 Banc De Sang I Teixits Composition for regenerating bony tissue, method for preparation and use thereof
US10881693B2 (en) 2019-04-09 2021-01-05 Combangio, Inc. Processes for making and using a mesenchymal stem cell derived secretome
AU2021251785A1 (en) 2020-04-07 2022-11-03 Combangio, Inc. Lyophilized mesenchymal stem cell derived secretome and uses thereof
CN111760064A (en) * 2020-08-25 2020-10-13 重庆大学附属肿瘤医院 A kind of dressing for treating diabetic foot and preparation method thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012205269B2 (en) 2004-03-22 2015-08-27 Mesoblast International Sarl Mesenchymal stem cells and uses therefor
US8709081B2 (en) * 2006-10-23 2014-04-29 Stemedica Cell Technologies, Inc. Cellular scaffold
KR101101321B1 (en) 2008-11-03 2012-01-02 주식회사 엠씨티티 Hydrogel-type cell delivery vehicle for wound healing and preparation method thereof
EP2358301B1 (en) 2008-11-25 2019-07-17 The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. Regenerative tissue grafts and methods of making same
KR101109125B1 (en) 2009-03-24 2012-02-15 한국과학기술연구원 Method to differentiate stem cells into vascular cells and induction of angiogenesis in vivo
ES2677945T3 (en) * 2009-08-25 2018-08-07 Servicio Andaluz De Salud Production of artificial tissues by tissue engineering using fibrin and agarose biomaterials
WO2011088365A1 (en) * 2010-01-14 2011-07-21 Organogenesis, Inc. Bioengineered tissue constructs and methods for producing and using thereof
ITMI20100601A1 (en) * 2010-04-09 2011-10-10 Luisa Benassi "NEW DERMIC SUBSTITUTE AND ITS THERAPEUTIC APPLICATION"
WO2012131618A1 (en) 2011-03-30 2012-10-04 Stempeutics Research Private Limited A composition comprising pooled wharton's jelly derived mesenchymal stem cells and methods thereof
SG11201501024QA (en) * 2012-08-15 2015-03-30 Univ Singapore Wound dressing nanomesh impregnated with human umbilical cord wharton's jelly stem cells

Also Published As

Publication number Publication date
WO2015058318A1 (en) 2015-04-30

Similar Documents

Publication Publication Date Title
MX377544B (en) TOPICAL COMPOSITIONS COMPRISING A CORTICOSTEROID AND A RETINOID FOR TREATMENT OF PSORIASIS.
NI201600051A (en) COMBINATIONS OF HISTONE DESACETILASE INHIBITORS AND IMMUNOMODULATING DRUGS
MX370506B (en) Method for treating post-traumatic stress disorder.
MX387753B (en) Plasma kallikrein-binding proteins and their uses to treat hereditary angioedema.
MX2018006578A (en) Topical pharmaceutical formulations for treating inflammatory-related conditions.
MX2017010773A (en) Pd-1 / pd-l1 inhibitors for the treatment of cancer.
BR112017018954A2 (en) Use of Ras Protein Mutant Form and Method to Treat Cancer
CL2018001258A1 (en) Methods for treating conditions associated with activation of the masp-2-dependent complement
CL2015002708A1 (en) Heterocyclic compounds and their uses.
EP3092989C0 (en) BIODEGRADABLE OR NON-BIODEGRADABLE COMPOSITION OF MESENCHYMAL STEM CELLS AND HYDROGEL TO SUPPORT SKIN REGENERATION OR WOUND HEALING
EA201792496A1 (en) METHODS OF TREATMENT OF INFLAMMATION OR NEUROPATHIC PAIN
MX2017016024A (en) Nicotinamide riboside and pterostilbene compositions and methods for treatment of skin disorders.
BR112013017506A2 (en) wound and skin care devices and methods
CR20160308A (en) COMBINATIONS OF INHIBITORS OF HISTONA DEACETILASE AND IMMUNOMODULATING PHARMACOS
IL254863A0 (en) Formulation and process for regulating wound healing
CL2017002774A1 (en) Improved uricase sequences and treatment methods
CL2016000326A1 (en) Compositions and method to treat conditions associated with the complement
BR112015028193B8 (en) SUPPORT FOR WOUND HEALING
CR20140573A (en) NAMPT INHIBITORS
BR112013023227A2 (en) Method for treating loss of circulation, and lost gelling circulation material (lcm)
MX2019009783A (en) METHOD TO MANUFACTURE A BAR THAT INCLUDES ANTI-TRANSPIRANT.
CL2013003066A1 (en) Composition for treatment of wounds because it comprises support matrix and stem cells mesenchymics of wharton jelly; method for treating wounds comprising applying said composition
MX2016006656A (en) METHODS TO TREAT REJECTION MEDIATED BY ANTIBODIES IN ORGAN TRANSPLANTATION PATIENTS WITH C1-ESTERASE INHIBITOR.
UY37534A (en) METHOD FOR THE TREATMENT OF FIBROTIC DISEASES USING INTERFERON-LAMBDA
IL269550A (en) Preparations and methods for treating diseases related to alpha-synuclein